Medicines developed with artificial intelligence could help overcome the growing health crisis in the future. Researchers at the Massachusetts Institute of Technology (MIT) have used generative artificial intelligence (AI) to design new compounds that can eliminate bacteria that have developed resistance to existing antibiotics.
According to scientists, the most striking aspect of this achievement is that complex computer models designed drug molecules in a way that not only destroys the structure of bacteria but also reduces the chances of them developing resistance again.
The failure of antibiotics is a growing crisis worldwide. According to the World Health Organization (WHO), millions of people die every year from infections that are resistant to common drugs. Scientists say that if the crisis is not controlled, even minor illnesses can become fatal.
Professor James Collins, who led the research, said: “We have created compounds that can break
through biological barriers and kill the most dangerous bacteria. This work was completed many times faster than human research because artificial intelligence showed us paths that we had not seen before.”
Experts believe that systems like Generative AI could change the entire pharmaceutical process in the future. While it currently takes years and billions of dollars to bring a new drug to market, this technology could deliver more effective results in less time and at lower cost.
The results of this research have been published in the renowned scientific journal “Nature” and initial experiments have proven successful. The next step will be to test these compounds in humans to see if they are safe and effective.
Health experts say that if this technology advances successfully, it could revolutionize the fight against antibiotic resistance and save humanity from a potential future medical crisis.
